pteridines and xanthine

pteridines has been researched along with xanthine in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19904 (14.29)18.7374
1990's11 (39.29)18.2507
2000's8 (28.57)29.6817
2010's4 (14.29)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Blankenship, PR; Bowyer, F; Hommes, FA; Roesel, RA1
Johnson, JL; Mandell, R; Shih, VE; Wuebbens, MM1
Archer, M; Engh, R; Hof, P; Huber, R; LeGall, J; Moura, I; Moura, JJ; Romão, MJ; Schneider, M1
Mandel, H; Stroomer, LE; van Cruchten, AG; van Gennip, AH1
Hille, R; Kim, JH; Knaut, H; Ryan, MG1
Bray, RC; Burke, JF; Chovnick, A; Doyle, WA; Dutton, FL; Whittle, JR1
Bellini, C; Bertola, A; Bonioli, E; Caruso, U; DiStefano, A; Dorche, C; Fantasia, AR; Minniti, G; Palmieri, A1
Sumi, S; Wada, Y1
Amaya, Y; Hosoya, T; Ichida, K; Kamatani, N; Nishino, T; Sakai, O1
Hosoya, T; Ichida, K1
Ishibashi, S; Matsuishi, T; Nakashima, M; Satoi, M1
Grisham, MB; Koyama, S; Robbins, RA; Sato, E; Simpson, KL1
Angermüller, S; Klipp, W; Leimkühler, S; Mendel, RR; Schwarz, G1
Fujita, T; Ihara, N; Itoh, T; Sugimoto, Y; Watanabe, T1
Jones, L; Kim, JH; Odutola, JA; Popham, J; von Laven, S1
Adham, IM; Engel, W; Kneussel, M; Lee, HJ; Reiss, J; Sass, JO; Schwarz, G1
Ichida, K2
BROWN, GB; CRESSWELL, RM; MAURER, HK; STRAUSS, T1
Al-Ahaidib, L; Al-Amoudi, M; Al-Shahwan, S; Eyaid, W; Jacob, M; Osman, ME; Rahbeeni, Z; Rashed, MS; Saadallah, AA; Salih, MA; Seidahmed, MZ1
HOFSTEE, BH1
Cao, H; Hille, R; Pauff, JM1
Affandi, O; Afroze, B; Chen, BC; Ngu, LH; Zabedah, MY1
Hwang, KC; Tai, LA1
Kusano, T; Nishino, T; Okamoto, K1
Nishino, T; Okamoto, K1
Brueck, W; Burfeind, P; Hakroush, S; Jakubiczka-Smorag, J; Kumar, A; Metz, I; Reiss, J; Santamaria-Araujo, JA; Schwarz, G; Smorag, L1
Agili, F; El-Kalyoubi, S1

Reviews

7 review(s) available for pteridines and xanthine

ArticleYear
[Xanthine oxidase deficiency (hereditary xanthinuria), molybdenum cofactor deficiency].
    Nihon rinsho. Japanese journal of clinical medicine, 1996, Volume: 54, Issue:12

    Topics: Central Nervous System Diseases; Coenzymes; Diagnosis, Differential; Diet Therapy; Humans; Infant, Newborn; Metalloproteins; Molybdenum Cofactors; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Seizures; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines

1996
[Classical xanthinuria (type I and II)].
    Ryoikibetsu shokogun shirizu, 1998, Issue:18 Pt 1

    Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Coenzymes; Diagnosis, Differential; Humans; Metalloproteins; Molybdenum Cofactors; Mutation; Oxidoreductases Acting on Sulfur Group Donors; Prognosis; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Purines; Urinary Calculi; Xanthine; Xanthine Dehydrogenase

1998
[Molybdenum cofactor deficiency].
    Ryoikibetsu shokogun shirizu, 1998, Issue:19 Pt 2

    Topics: Biomarkers; Coenzymes; Cysteine; Diagnosis, Differential; Female; Humans; Infant; Infant, Newborn; Male; Metal Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Sulfites; Xanthine

1998
[Primary underproductive hypouricemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 1

    Topics: Allopurinol; Coenzymes; Diagnosis, Differential; Humans; Liver Diseases; Metalloproteins; Molybdenum Cofactors; Prognosis; Pteridines; Purine-Nucleoside Phosphorylase; Purine-Pyrimidine Metabolism, Inborn Errors; Ribose-Phosphate Pyrophosphokinase; Uric Acid; Xanthine

2003
[Hereditary xanthinuria and molybdenum cofactor deficiency].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 1

    Topics: Coenzymes; Genes, Recessive; Humans; Metalloproteins; Molybdenum Cofactors; Mutation; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Uric Acid; Xanthine; Xanthine Dehydrogenase

2003
Chemical nature and reaction mechanisms of the molybdenum cofactor of xanthine oxidoreductase.
    Current pharmaceutical design, 2013, Volume: 19, Issue:14

    Topics: Animals; Coenzymes; Drug Discovery; Electron Transport; Humans; Hydrogen Bonding; Hydroxylation; Metalloproteins; Models, Molecular; Molybdenum Cofactors; Nitric Oxide; Oxidation-Reduction; Protein Binding; Pteridines; Substrate Specificity; Uric Acid; Xanthine; Xanthine Dehydrogenase

2013
Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2015, Volume: 20, Issue:2

    Topics: Catalytic Domain; Coenzymes; Enzyme Inhibitors; Gout; Humans; Hyperuricemia; Metalloproteins; Molybdenum Cofactors; Pteridines; Xanthine; Xanthine Dehydrogenase

2015

Other Studies

21 other study(ies) available for pteridines and xanthine

ArticleYear
Combined xanthine and sulphite oxidase defect due to a deficiency of molybdenum cofactor.
    Journal of inherited metabolic disease, 1986, Volume: 9, Issue:4

    Topics: Coenzymes; Humans; Infant, Newborn; Liver; Male; Metabolism, Inborn Errors; Metalloproteins; Molybdenum Cofactors; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Sulfites; Xanthine; Xanthine Oxidase; Xanthines

1986
Molybdenum cofactor deficiency in a patient previously characterized as deficient in sulfite oxidase.
    Biochemical medicine and metabolic biology, 1988, Volume: 40, Issue:1

    Topics: Cells, Cultured; Coenzymes; Fibroblasts; Humans; Hypoxanthine; Hypoxanthines; Infant; Male; Metalloproteins; Molybdenum; Molybdenum Cofactors; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthines

1988
Crystal structure of the xanthine oxidase-related aldehyde oxido-reductase from D. gigas.
    Science (New York, N.Y.), 1995, Nov-17, Volume: 270, Issue:5239

    Topics: Aldehyde Oxidoreductases; Amino Acid Sequence; Animals; Coenzymes; Crystallization; Crystallography, X-Ray; Cytosine Nucleotides; Desulfovibrio; Drosophila melanogaster; Electron Transport; Hydrogen Bonding; Iron; Ligands; Metalloproteins; Molecular Sequence Data; Molybdenum; Molybdenum Cofactors; Oxidation-Reduction; Protein Conformation; Protein Folding; Protein Structure, Secondary; Pteridines; Pterins; Xanthine; Xanthine Oxidase; Xanthines

1995
Effect of allopurinol on the xanthinuria in a patient with molybdenum cofactor deficiency.
    Advances in experimental medicine and biology, 1994, Volume: 370

    Topics: Allopurinol; Coenzymes; Female; Humans; Male; Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; Xanthine; Xanthine Dehydrogenase; Xanthines

1994
The reductive half-reaction of xanthine oxidase. The involvement of prototropic equilibria in the course of the catalytic sequence.
    The Journal of biological chemistry, 1996, Mar-22, Volume: 271, Issue:12

    Topics: Catalysis; Electron Spin Resonance Spectroscopy; Fluorescent Dyes; Hydrogen-Ion Concentration; Kinetics; Molybdenum; Oxidation-Reduction; Pteridines; Purines; Solvents; Substrate Specificity; Xanthine; Xanthine Oxidase; Xanthines

1996
Properties of xanthine dehydrogenase variants from rosy mutant strains of Drosophila melanogaster and their relevance to the enzyme's structure and mechanism.
    European journal of biochemistry, 1996, Aug-01, Volume: 239, Issue:3

    Topics: Amino Acid Sequence; Animals; Binding Sites; Coenzymes; Conserved Sequence; Cross Reactions; Drosophila melanogaster; Enzyme Activation; Genetic Variation; Kinetics; Metalloproteins; Molecular Sequence Data; Molybdenum Cofactors; Mutagenesis, Site-Directed; Mutation; NAD; Oxidation-Reduction; Pteridines; Sequence Homology, Amino Acid; Structure-Activity Relationship; Xanthine; Xanthine Dehydrogenase; Xanthines

1996
Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor.
    Journal of inherited metabolic disease, 1996, Volume: 19, Issue:5

    Topics: Coenzymes; Female; Fibroblasts; Humans; Hypoxanthine; Infant; Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines

1996
Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.
    The Journal of clinical investigation, 1997, May-15, Volume: 99, Issue:10

    Topics: Adult; Aged; Codon; Coenzymes; DNA Primers; Duodenum; Humans; Intestinal Mucosa; Male; Metalloproteins; Molybdenum; Molybdenum Cofactors; Point Mutation; Polymerase Chain Reaction; Pteridines; Purine-Pyrimidine Metabolism, Inborn Errors; RNA, Messenger; Sequence Deletion; Xanthine; Xanthine Dehydrogenase; Xanthines

1997
Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.
    The American journal of pathology, 1999, Volume: 155, Issue:2

    Topics: Chemokine CCL5; Chemotaxis; Deferoxamine; Dithiothreitol; Dose-Response Relationship, Drug; Eosinophils; Humans; Hydrazines; Interleukin-5; Leukotriene B4; Molsidomine; Nitrates; Nitric Oxide; Nitrogen; Pteridines; Reactive Oxygen Species; Superoxides; Tyrosine; Xanthine

1999
Activity of the molybdopterin-containing xanthine dehydrogenase of Rhodobacter capsulatus can be restored by high molybdenum concentrations in a moeA mutant defective in molybdenum cofactor biosynthesis.
    Journal of bacteriology, 1999, Volume: 181, Issue:19

    Topics: Amino Acid Sequence; Coenzymes; DNA Mutational Analysis; Escherichia coli; Escherichia coli Proteins; Eukaryotic Cells; Guanine Nucleotides; Iron-Sulfur Proteins; Metalloproteins; Models, Biological; Molecular Sequence Data; Molybdenum; Molybdenum Cofactors; Mutagenesis, Insertional; Mutation; Nitrate Reductases; Organometallic Compounds; Oxidoreductases; Pteridines; Rhodobacter capsulatus; Sequence Homology, Amino Acid; Sulfurtransferases; Xanthine; Xanthine Oxidase

1999
Deletion mutation in Drosophila ma-l homologous, putative molybdopterin cofactor sulfurase gene is associated with bovine xanthinuria type II.
    The Journal of biological chemistry, 2000, Jul-21, Volume: 275, Issue:29

    Topics: Amino Acid Sequence; Animals; Cattle; Cattle Diseases; Coenzymes; Drosophila; Genes, Insect; Metalloproteins; Molecular Sequence Data; Molybdenum Cofactors; Pteridines; Sequence Deletion; Sequence Homology, Amino Acid; Xanthine; Xanthine Dehydrogenase

2000
Tautomeric energetics of xanthine oxidase substrates: xanthine, 2-oxo-6-methylpurine, and lumazine.
    Journal of inorganic biochemistry, 2001, Volume: 84, Issue:1-2

    Topics: Catalysis; Energy Metabolism; In Vitro Techniques; Isomerism; Pteridines; Purines; Quantum Theory; Substrate Specificity; Thermodynamics; Xanthine; Xanthine Oxidase

2001
Molybdenum cofactor-deficient mice resemble the phenotype of human patients.
    Human molecular genetics, 2002, Dec-15, Volume: 11, Issue:26

    Topics: Animals; Carbon-Carbon Lyases; Coenzymes; Disease Models, Animal; Humans; Metalloproteins; Mice; Mice, Transgenic; Molybdenum Cofactors; Nuclear Proteins; Pteridines; Sulfites; Uric Acid; Xanthine; Xanthine Dehydrogenase

2002
PURINE N-OXIDES. XIV. A TOTAL SYNTHESIS OF A PYRIMIDINE N-OXIDE, A PTERIDINE 1-N-OXIDE, AND XANTHINE 3-N-OXIDE.
    The Journal of organic chemistry, 1965, Volume: 30

    Topics: Chemical Phenomena; Chemistry; Oxides; Pteridines; Pterins; Purines; Pyrimidines; Research; Xanthine; Xanthines

1965
Determination of urinary S-sulphocysteine, xanthine and hypoxanthine by liquid chromatography-electrospray tandem mass spectrometry.
    Biomedical chromatography : BMC, 2005, Volume: 19, Issue:3

    Topics: Adult; Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Chromatography, Liquid; Coenzymes; Cysteine; Humans; Hypoxanthine; Infant; Infant, Newborn; Metalloproteins; Molybdenum Cofactors; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Spectrometry, Mass, Electrospray Ionization; Xanthine

2005
Inhibition of the enzymic oxidation of xanthine and xanthopterin by pteridines.
    The Journal of biological chemistry, 1949, Volume: 179, Issue:2

    Topics: Oxidation-Reduction; Pteridines; Xanthine; Xanthines; Xanthopterin

1949
Substrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase: CRYSTAL STRUCTURES IN COMPLEX WITH XANTHINE AND LUMAZINE.
    The Journal of biological chemistry, 2009, Mar-27, Volume: 284, Issue:13

    Topics: Animals; Bacterial Proteins; Catalysis; Catalytic Domain; Cattle; Crystallography, X-Ray; Female; Milk; Molybdenum; Protein Structure, Tertiary; Pteridines; Rhodobacter capsulatus; Xanthine; Xanthine Oxidase

2009
Molybdenum cofactor deficiency in a Malaysian child.
    Singapore medical journal, 2009, Volume: 50, Issue:10

    Topics: Brain Diseases; Child; Coenzymes; Cysteine; Diagnosis, Differential; Humans; Hypoxanthine; Hypoxia; Ischemia; Malaysia; Male; Metalloproteins; Molybdenum Cofactors; Pteridines; Sulfites; Uric Acid; Xanthine

2009
Regulation of xanthine oxidase activity by substrates at active sites via cooperative interactions between catalytic subunits: implication to drug pharmacokinetics.
    Current medicinal chemistry, 2011, Volume: 18, Issue:1

    Topics: Adenine; Binding Sites; Catalysis; Catalytic Domain; Dimerization; Enzyme Inhibitors; Humans; Models, Theoretical; Protein Binding; Pteridines; Pterins; Substrate Specificity; Xanthine; Xanthine Oxidase; Xanthopterin

2011
Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.
    Human genetics, 2016, Volume: 135, Issue:7

    Topics: Animals; Apoptosis; Carbon-Carbon Lyases; Coenzymes; Cysteine; Disease Models, Animal; Gene Expression; Humans; Hypoxanthine; Metal Metabolism, Inborn Errors; Metalloproteins; Mice; Mice, Knockout; Molybdenum Cofactors; Mutation; Nuclear Proteins; Phenotype; Pteridines; Xanthine

2016
Synthesis, In Silico Prediction and In Vitro Evaluation of Antitumor Activities of Novel Pyrido[2,3-
    Molecules (Basel, Switzerland), 2020, Nov-09, Volume: 25, Issue:21

    Topics: A549 Cells; Antineoplastic Agents; Binding Sites; Chemistry Techniques, Synthetic; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Folic Acid; Humans; Inhibitory Concentration 50; Janus Kinase 2; MCF-7 Cells; Molecular Docking Simulation; Neoplasms; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Pteridines; Pyridines; Pyrimidines; Tetrahydrofolate Dehydrogenase; Tumor Suppressor Protein p53; Xanthine

2020